125 related articles for article (PubMed ID: 12537998)
1. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines.
Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Nishizaki M; Naka M; Komeno M; Nakai H; Toda M
Bioorg Med Chem; 2003 Mar; 11(5):689-702. PubMed ID: 12537998
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines.
Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Nakai H; Toda M
Bioorg Med Chem Lett; 2002 Sep; 12(17):2291-4. PubMed ID: 12161118
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Identification of 2-azabicyclo[4.1.0]heptan-3-imines.
Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Odagaki Y; Nakai H; Toda M
Bioorg Med Chem; 2003 Apr; 11(8):1723-43. PubMed ID: 12659759
[TBL] [Abstract][Full Text] [Related]
4. 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).
Hansen DW; Peterson KB; Trivedi M; Kramer SW; Webber RK; Tjoeng FS; Moore WM; Jerome GM; Kornmeier CM; Manning PT; Connor JR; Misko TP; Currie MG; Pitzele BS
J Med Chem; 1998 Apr; 41(9):1361-6. PubMed ID: 9554868
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of inhibitors of inducible nitric oxide synthase. Discovery of a new chemical lead with potential for oral bioavailability.
Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Nakai H; Toda M
Eur J Med Chem; 2003 Mar; 38(3):277-88. PubMed ID: 12667694
[TBL] [Abstract][Full Text] [Related]
6. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
Hagen TJ; Bergmanis AA; Kramer SW; Fok KF; Schmelzer AE; Pitzele BS; Swenton L; Jerome GM; Kornmeier CM; Moore WM; Branson LF; Connor JR; Manning PT; Currie MG; Hallinan EA
J Med Chem; 1998 Sep; 41(19):3675-83. PubMed ID: 9733492
[TBL] [Abstract][Full Text] [Related]
7. Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.
Webber RK; Metz S; Moore WM; Connor JR; Currie MG; Fok KF; Hagen TJ; Hansen DW; Jerome GM; Manning PT; Pitzele BS; Toth MV; Trivedi M; Zupec ME; Tjoeng FS
J Med Chem; 1998 Jan; 41(1):96-101. PubMed ID: 9438025
[TBL] [Abstract][Full Text] [Related]
8. Novel and orally bioavailable inducible nitric oxide synthase inhibitors: synthesis and evaluation of optically active 4,5-dialkyl-2-iminoselenazolidine derivatives.
Ueda S; Terauchi H; Suzuki K; Yano A; Matsumoto M; Kubo T; Minato H; Arai Y; Tsuji J; Watanabe N
Bioorg Med Chem Lett; 2005 Mar; 15(5):1361-6. PubMed ID: 15713387
[TBL] [Abstract][Full Text] [Related]
9. 3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitor.
Tsymbalov S; Hagen TJ; Moore WM; Jerome GM; Connor JR; Manning PT; Pitzele BS; Hallinan EA
Bioorg Med Chem Lett; 2002 Nov; 12(22):3337-9. PubMed ID: 12392746
[TBL] [Abstract][Full Text] [Related]
10. Acetamidine lysine derivative, N-(5(S)-amino-6,7-dihydroxyheptyl)ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase.
Hallinan EA; Tsymbalov S; Finnegan PM; Moore WM; Jerome GM; Currie MG; Pitzele BS
J Med Chem; 1998 Mar; 41(6):775-7. PubMed ID: 9526553
[No Abstract] [Full Text] [Related]
11. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
Fishlock D; Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E; Lajoie GA
Bioorg Med Chem; 2003 Mar; 11(6):869-73. PubMed ID: 12614872
[TBL] [Abstract][Full Text] [Related]
12. 1H-pyrazole-1-carboxamidines: new inhibitors of nitric oxide synthase.
Lee Y; Martásek P; Roman LJ; Silverman RB
Bioorg Med Chem Lett; 2000 Dec; 10(24):2771-4. PubMed ID: 11133088
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase.
Shankaran K; Donnelly KL; Shah SK; Guthikonda RN; MacCoss M; Humes JL; Pacholok SG; Grant SK; Kelly TM; Wong KK
Bioorg Med Chem Lett; 2004 Sep; 14(17):4539-44. PubMed ID: 15357988
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase.
Jackson SA; Sahni S; Lee L; Luo Y; Nieduzak TR; Liang G; Chiang Y; Collar N; Fink D; He W; Laoui A; Merrill J; Boffey R; Crackett P; Rees B; Wong M; Guilloteau JP; Mathieu M; Rebello SS
Bioorg Med Chem; 2005 Apr; 13(8):2723-39. PubMed ID: 15781384
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and evaluation of new type of L-amino acids containing pyridine moiety as nitric oxide synthase inhibitor.
Ijuin R; Umezawa N; Higuchi T
Bioorg Med Chem; 2006 May; 14(10):3563-70. PubMed ID: 16466923
[TBL] [Abstract][Full Text] [Related]
16. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
17. Thienopyridines: nitric oxide synthase inhibitors with potent in vivo activity.
Beaton H; Boughton-Smith N; Hamley P; Ghelani A; Nicholls DJ; Tinker AC; Wallace AV
Bioorg Med Chem Lett; 2001 Apr; 11(8):1027-30. PubMed ID: 11327581
[TBL] [Abstract][Full Text] [Related]
18. Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase.
Guthikonda RN; Shah SK; Pacholok SG; Humes JL; Mumford RA; Grant SK; Chabin RM; Green BG; Tsou N; Ball R; Fletcher DS; Luell S; Euan MacIntyre D; Maccoss M
Bioorg Med Chem Lett; 2005 Apr; 15(8):1997-2001. PubMed ID: 15808455
[TBL] [Abstract][Full Text] [Related]
19. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
[TBL] [Abstract][Full Text] [Related]
20. 4,5-dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors.
Ueda S; Terauchi H; Yano A; Matsumoto M; Kubo T; Kyoya Y; Suzuki K; Ido M; Kawasaki M
Bioorg Med Chem; 2004 Aug; 12(15):4101-16. PubMed ID: 15246088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
